# Cetrorelix

## Cetrotide inj 0.25mg

| 藥物代碼 | ICETR |
| :--- | :--- |
| 適應症 | Hypersensitivity to extrinsic peptide hormones or mannitol. Postmenopausal women, moderate & severe renal or hepatic impairment. Pregnancy, lactation. |
| 副作用 | Reactions at inj site, nausea, headache, ovarian hyperstimulation syndrome. |
| 禁忌 | Prevention of premature ovulation in patients undergoing controlled ovarian stimulation, followed by oocyte pick-up & assisted reproduction techniques. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | SC inj Cetrotide 0.25 mg Administration in the morning 1 vial once daily commencing on day 5 or 6 of ovarian stimulation \(approx 96-120 hr after initiation of ovarian stimulation\). Administration in the evening 1 vial once daily on day 5 of ovarian stimulation \(approx 96-108 hr\) after initiation of ovarian stimulation. To be given w/ urinary or recombinant gonadotrophins & continued throughout gonadotrophin treatment until the evening prior to the day of ovulation induction. |
| 肝功能異常 | 無需調整劑量  肝功能不全者無相關研究,應謹慎使用 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 不可使用 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | H, SC |
| 乾粉稀釋液 | 使用廠商提供之注射用水稀釋,以溫和旋轉方式來溶解,避免劇烈搖晃產生氣泡 |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

